Bone marrow-derived mesenchymal stem cells for treatment of heart failure: is it all paracrine actions and immunomodulation?

Journal of Cardiovascular Medicine
Pankaj Kumar Mishra

Abstract

Despite significant advances in medical and surgical management of heart failure, mostly of ischaemic origin, the mortality and morbidity associated with it continue to be high. Pluripotent stem cells are being evaluated for treatment of heart failure. Bone marrow-derived mesenchymal stem cells (MSCs) have been extensively studied. Emerging evidence suggests that locally delivered MSCs can lead to an improvement in ventricular function, but the cellular and molecular mechanisms involved remain unclear. Myocardial regeneration, as proposed by many researchers as the underlying mechanism, has failed to convince the scientific community. Recently some authors have ascribed improvement in ventricular function to paracrine actions of MSCs.A lot has been written about the host immune response triggered by embryonic stem cells and the consequent need for immunosuppression. Not enough work has been done on immune interactions involving allogeneic bone marrow cells. Full potential of stem cell therapy can be realised only when we are able to use allogeneic cells. The potential use of MSCs in cellular therapy has recently prompted researchers to look into their interaction with the host immune response. MSCs have immunomodulatory propert...Continue Reading

References

Jan 1, 1995·Annual Review of Medicine·M A Pfeffer
Aug 1, 1995·Biochemical Society Transactions·B Van den EyndeT Boon
Feb 1, 1996·Journal of Hematotherapy·S Gronthos, P J Simmons
Sep 1, 1996·The Annals of Thoracic Surgery·R K LiJ Ivanov
Apr 2, 1999·Science·M F PittengerD R Marshak
Jun 3, 1999·European Journal of Clinical Investigation·A SarasteL M Voipio-Pulkki
Oct 3, 1999·The Journal of Thoracic and Cardiovascular Surgery·T SakaiT M Yau
Dec 14, 1999·Circulation·J T Willerson
Jan 5, 2000·The Annals of Thoracic Surgery·T SakaiT M Yau
Apr 5, 2001·Nature·D OrlicP Anversa
Jun 8, 2001·The Journal of Clinical Investigation·K A JacksonM A Goodell
Jul 19, 2001·Annals of the New York Academy of Sciences·D OrlicP Anversa
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·D OrlicP Anversa
Oct 3, 2001·The Journal of Thoracic and Cardiovascular Surgery·J S WangR C Chiu
Feb 2, 2002·Experimental Hematology·Amelia BartholomewRonald Hoffman
Apr 17, 2002·Circulation·Claude Lenfant
Jun 25, 2002·The Annals of Thoracic Surgery·Jay G ShakeBradley J Martin
Dec 14, 2002·Circulation Research·Donald OrlicAndrew E Arai
Jan 9, 2003·Lancet·Christof StammGustav Steinhoff
Feb 22, 2003·Journal of Biomedical Science·Manas K MajumdarJoseph D Mosca
Mar 21, 2003·The Annals of Thoracic Surgery·Masahiko NishidaKimikazu Hamano
May 7, 2003·Gene Therapy·C JorgensenD Noël
Sep 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julius A PotianPranela Rameshwar
Dec 16, 2003·Birth Defects Research. Part C, Embryo Today : Reviews·Frank P Barry
Feb 28, 2004·Expert Reviews in Molecular Medicine·Roshni MitraAshok Khar
Mar 3, 2004·The Annals of Thoracic Surgery·Juan C ChachquesAlain F Carpentier
Mar 11, 2004·The International Journal of Biochemistry & Cell Biology·Frank P Barry, J Mary Murphy

❮ Previous
Next ❯

Citations

Feb 11, 2009·Antioxidants & Redox Signaling·Hyongbum KimYoung-Sup Yoon
Dec 15, 2010·Current Opinion in Organ Transplantation·Juan Domínguez-BendalaCamillo Ricordi
Nov 5, 2010·American Journal of Physiology. Renal Physiology·Abolfazl ZarjouLisa M Curtis
Apr 28, 2009·Journal of Translational Medicine·Neil H RiordanBoris Minev
Dec 19, 2012·Regenerative Medicine·Camillo RicordiJuan Domínguez-Bendala
Jul 18, 2014·Journal of Cardiovascular Translational Research·Federico FranchiMartin Rodriguez-Porcel
Jul 20, 2012·Biochemical and Biophysical Research Communications·Woochul ChangKi-Chul Hwang
Jul 9, 2009·Journal of Cellular and Molecular Medicine·Abdelkrim HmadchaBernat Soria
Apr 29, 2009·Journal of Cellular and Molecular Medicine·Florian TögelChristof Westenfelder
Apr 22, 2010·European Journal of Heart Failure·Hagen MaxeinerSibylle Wenzel
Jan 5, 2011·Journal of Zhejiang University. Science. B·Zhou TanMing Zhang
Jul 24, 2014·The Angle Orthodontist·Abdullah EkizerFikrettin Sahin
Jan 8, 2020·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Federico FranchiMartin Rodriguez-Porcel
Mar 25, 2008·Pediatric Research·James C Y Dunn
Oct 22, 2015·Physiological Reports·Erica N ChiricoJoseph R Libonati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.